Kodiak Sciences (KOD) Prepaid Assets (2017 - 2026)
Kodiak Sciences' (KOD) quarterly Prepaid Assets came in at $5.7 million in Q1 2026, up 49.4% YoY from $3.8 million in Q1 2025, and up 15.62% on a QoQ basis from $5.0 million in Q4 2025.
Kodiak Sciences (KOD) Prepaid Assets (2017 - 2026) Analysis & Trends
Kodiak Sciences (KOD) has 10 years of Prepaid Assets data on file, last reported at $5.7 million in Q1 2026.
- Quarterly Prepaid Assets rose 49.4% year-over-year to $5.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.7 million (up 49.4% YoY) and the FY2025 annual result came in at $5.0 million, up 28.28% from the prior year.
- Prepaid Assets rose to $5.7 million in Q1 2026, from $5.0 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $10.5 million in Q1 2022 to a low of $3.7 million in Q3 2025.
- A 5-year average of $5.9 million and a median of $5.4 million in 2024 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2022 — Prepaid Assets surged 259.2% — and 2023, when it plunged 46.24%.
- Tracing KOD's Prepaid Assets over 5 years: stood at $7.1 million in 2022, then sank by 46.24% to $3.8 million in 2023, then rose by 1.58% to $3.9 million in 2024, then rose by 28.28% to $5.0 million in 2025, then grew by 15.62% to $5.7 million in 2026.
- The last three Prepaid Assets figures came in at $5.7 million (Q1 2026), $5.0 million (Q4 2025), and $3.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Kodiak Sciences | 2.60 Bn | 2.60 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.46 Mn |
| Mar 31, 2026 | 5.73 Mn |
| Dec 31, 2025 | 4.95 Mn |
| Sep 30, 2025 | 3.69 Mn |
| Jun 30, 2025 | 3.75 Mn |
| Mar 31, 2025 | 3.83 Mn |
| Dec 31, 2024 | 3.86 Mn |
| Sep 30, 2024 | 4.63 Mn |
| Jun 30, 2024 | 5.40 Mn |
| Mar 31, 2024 | 5.59 Mn |
| Dec 31, 2023 | 3.80 Mn |
| Sep 30, 2023 | 5.26 Mn |
| Jun 30, 2023 | 8.29 Mn |
| Mar 31, 2023 | 9.93 Mn |
| Dec 31, 2022 | 7.07 Mn |
| Sep 30, 2022 | 7.27 Mn |
| Jun 30, 2022 | 6.49 Mn |
| Mar 31, 2022 | 10.46 Mn |
| Dec 31, 2021 | 3.30 Mn |
| Sep 30, 2021 | 6.26 Mn |